Ranked in 1 Practice Areas
1

Band 1

Corporate/M&A: £100-800 million

London (Firms)

3 Years Ranked

Ranked in Guides

About

Provided by Simon D Morgan

UK

Work Highlights

Blue Prism, the robotic process automation software business, on its USD 1.65bn recommended offer from SS&C, following the USD 1.5bn recommended offer made for it by US private equity firm, Vista.

M&C Saatchi, the international marketing agency, on its successful defence of the hostile GBP 264m offer made for it by AdvancedAdvT and on the competitive GBP 310m offer made for it by Next15 Communications Group.

BBC Studios, on its GBP 255m acquisition of the ITV Group’s 50% interest in BritBox International, the leading British content TV streamer operating in nine countries.

FremantleMedia Group, on its acquisition of Asacha Media Group, a pan European TV production Group with TV production companies in France, Italy and the UK, on its acquisition of controlling interests in Element Pictures, 72 Films and Wildstar Films and on a series of investments in TV production companies.

BAE Systems on the sale of NetReveal, its financial crime detection business division, to SymphonyAI.

Gigaclear, and its principal shareholder, a fund advised by Infracapital, on an up to GBP 420m equity investment made by funds managed by Equitix.

Rank Group on its GBP 115m offer for online gaming operator, Stride Gaming.

Blue Prism on a GBP 100m equity placing in 2019 and a GBP 100m equity placing in 2020 and Rank Group on a GBP 70m equity placing in 2020.

ParentPay, a leading provider of education technology, on the acquisition by Montagu Private Equity, of a minority interest including the sale by Montagu Private Equity of ESS, an education solutions softare business, to ParentPay.

Syncona, the UK based life science investor, on its investment in a series of life science companies and on the USD 476m sale of Blue Earth Diagnostics, a developer of molecular imaging agents including one involved in the targeting of prostate cancer cells, to Bracco Imaging.

Freeline Therapeutics, a life science company focused on developing curative gene therapies for chronic systemic diseases, on a USD 120m Series C financing including funding from Syncona, Novo Holdings, Eventide Asset Management and Wellington Management Company.

Delancey advised fund, DV4, and management, on the sale of db Symmetry (dbS) to Tritax Big Box REIT valuing dbS at GBP 370m.

Practice Areas

Simon Morgan is a partner in the Corporate/M&A Team at CMS London. Simon has over 30 years' experience of advising on corporate transactional matters, advising clients across a number of business sectors including Lifesciences, communications and technology.

Clients include established domestic and international companies, public bodies, growing businesses, investment groups and professional intermediaries.

Education

Pembroke College, Cambridge

MA Law

1984

Law Society Finals, England and Wales

1985

Admitted as a solicitor in England and Wales

1987

Chambers Review

Provided by Chambers

UK

Corporate/M&A: £100-800 million - London (Firms)
1
Band 1

Simon Morgan is able to draw on deep experience when assisting clients in sophisticated corporate transactions. He acts for a diverse client base and is well versed in deals in the technology, life sciences and technology sectors, among others.

Strengths

Provided by Chambers

Discover other Lawyers at
CMS

Provided by Chambers
Filter by
Band

London (Firms)

Banking & Finance: Mid-Market

Alex Patience
4
Alex Patience
4
Band 4
Charles Kerrigan
4
Charles Kerrigan
4
Band 4
Tom Siggers
4
Tom Siggers
4
Band 4
Commercial and Corporate Litigation

Benedict Trust
5
Benedict Trust
5
Band 5
Luke Pardey
5
Luke Pardey
5
Band 5
Competition Law

Brian Sher
2
Brian Sher
Head of Competition Law
2
Band 2
Construction: Contentious

Adrian J Bell
1
Adrian J Bell
1
Band 1
Steven Williams
2
Steven Williams
2
Band 2
Matthew Taylor
6
Matthew Taylor
6
Band 6
Construction: Non-contentious

Alistair McGrigor
3
Alistair McGrigor
3
Band 3
David Parton
6
David Parton
6
Band 6
Construction: Professional Negligence

Martin Fox
1
Martin Fox
1
Band 1
Monica Lesny
2
Monica Lesny
2
Band 2
Corporate Crime & Investigations

Eoin O'Shea
4
Eoin O'Shea
4
Band 4
Corporate/M&A: £100-800 million

Simon D Morgan
1
Simon D Morgan
1
Band 1
Louise Wallace
3
Louise Wallace
3
Band 3
Corporate/M&A: £800 million and above

Charles Currier
5
Charles Currier
5
Band 5
Employment: Employer

Catherine Taylor
2
Catherine Taylor
2
Band 2
Melanie Lane
3
Melanie Lane
3
Band 3
Hannah Netherton
5
Hannah Netherton
5
Band 5
20 of 219 results